In addition, compared with clinically functioning somatotroph adenomas, silent somatotroph adenomas were more common in women, presented with a lower percentage of GH immunoreactive cells, and were more frequently plurihormonal (GH/PRL or GH/PRL/TSH). This evidence concerns the gene GH1 and familial isolated pituitary adenoma.